Information Provided By:
Fly News Breaks for July 14, 2017
TSRO
Jul 14, 2017 | 07:23 EDT
After CNBC yesterday morning reported that a sale of Tesaro is unlikely, Citi analyst Robyn Karnauskas reiterated her $180 per share standalone valuation for the company. The analyst believes Niraparib is competitive in the PARP space and sees upside to the current share price. Her $216 price target is based on 60% standalone and 40% takeover potential. Karnauskas keeps a Buy rating on Tesaro.
News For TSRO From the Last 2 Days
There are no results for your query TSRO